The Patent Finder

Tanox, Inc. (de, USA)

Also on record
Records under this name other than patents Tanox, Inc. (de, USA) holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Tanox, Inc. (de, USA)

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,927,592Method of Inhibiting Complement Activation
Formerly held
Lapsed on the fee record
Ended Apr 19, 2023 · High confidence
Lapsed on the fee recordEnded Apr 19, 2023High confidence
US 6,998,468ANTI-C2/C2A Inhibitors of Complement Activation
Formerly held
Term ended
Term ended Nov 21, 2022 · High confidence
Term endedTerm ended Nov 21, 2022High confidence
US 6,534,058ANTI-C5 Monoclonal Antibodies
Formerly held
Term ended
Term ended Oct 4, 2021 · High confidence
Term endedTerm ended Oct 4, 2021High confidence
US 7,432,356Complement Pathway Inhibitors Binding to C5 and C5A Without Preventing Formation of C5B
Formerly held
Lapsed on the fee record
Ended Oct 7, 2020 · High confidence
Lapsed on the fee recordEnded Oct 7, 2020High confidence
US 7,118,743Bispecific Molecules Cross-Linking Itim and Itam for Therapy
Formerly held
Term ended
Term ended Nov 17, 2019 · Medium confidence
Term endedTerm ended Nov 17, 2019Medium confidence
US 6,956,107Inhibitors of Complement Activation
Formerly held
Term ended
Term ended Feb 20, 2019 · Medium confidence
Term endedTerm ended Feb 20, 2019Medium confidence
US 7,112,327Inhibition of Complement Activation
Formerly held
Term ended
Term ended Feb 20, 2019 · Medium confidence
Term endedTerm ended Feb 20, 2019Medium confidence
US 7,439,331Inhibition of Complement Activation
Formerly held
Term ended
Term ended Feb 20, 2019 · Medium confidence
Term endedTerm ended Feb 20, 2019Medium confidence
US 7,943,135Method of Treatment Using Anti-Factor D Antibodies
Formerly held
Term ended
Term ended Feb 20, 2019 · Medium confidence
Term endedTerm ended Feb 20, 2019Medium confidence
US 6,657,050Chimeric viral-neutralizing immunoglobulins
Formerly held
Lapsed on the fee record
Ended Dec 2, 2015 · USPTO record
Lapsed on the fee recordEnded Dec 2, 2015USPTO record
10 of 44 patents shown.
Pro members see all 44.
Pro members: see all 44 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited